We are a research-focused charity funding novel and innovative projects that matter to people affected by prostate cancer. Our research is working towards breakthroughs in the prevention, diagnosis and treatment of advanced prostate cancer, and better quality of life outcomes for patients.

Our research is supported by Trusts and Foundations that enable us to focus on the development of vital treatments for advanced prostate cancer.

By partnering with Prostate Cancer Research, you can help us to increase our impact either by supporting a specific research project or our core costs, which ensures that we are focused on working with great scientists and enabling great research.

If you would like to find out more about supporting the work of PCR, please contact Boris Cooper at [email protected].

Contact us

Impact & Financial Report

To find out more about our impact, our approach to funding medical research and our strategic goals, please read our Impact & Financial Report.
Impact & Financial Report 2019-20

Thank you to our supporters

We are delighted by the generous donations of our Trust and Foundation supporters.

The Nicol 2011 Trust

Supporting the discovery of new classifications and treatments for advanced prostate cancer

In 2019, The Nicol 2011 Trust awarded Prostate Cancer Research an incredible donation of over $790,000 in support of our new medical research projects. Established by the late Gordon Nicol, the Trust has made a significant contribution to the future of prostate cancer research as PCR aims to save and improve the lives of men and their families.

The donation will be used to support our new projects at leading prostate cancer research institutions, ranging from early-stage research to drug development for the treatment of advanced prostate cancer. We are tackling the problem of how to make prostate cancer treatment more effective in different ways.

In honor of Gordon’s contribution to prostate cancer research, we are proud to announce the creation of ‘The Gordon Nicol Award’, which has been awarded to Professor Iain J McEwan at the University of Aberdeen. Professor McEwan is working on a potentially major step forward in the treatment of advanced prostate cancer by preventing the development of hormone therapy-resistance amongst men.


Find out more about The Nicol 2011 Trust’s donation

The Barbara Naylor Charitable Trust.

Prostate Cancer Research is grateful for the generous support of The Barbara Naylor Charitable Trust.

With the Trust’s donation towards our Immunotherapy Project, we aim to develop a new immunotherapeutic treatment for advanced prostate cancer. Dr Christine Galustian and her team at King’s College London are working to harness the immune system’s innate ability to fight cancer.

Immunotherapy is one of the most exciting scientific advances in recent years. Dr Galustian has devised an innovative new way to harness a naturally-occurring protein’s ability to identify and treat cancerous cells, attaching it directly at the site of the tumor.

The next step is focused on bringing this new treatment to clinical trials. The Barbara Naylor Charitable Trust is helping us to achieve this.

Press enter or esc to cancel